With notified body capacity constraints creating bottlenecks in 2026, QbD Group experts discuss strategies for medical device manufacturers to navigate the EU MDR transition, including early engagement with notified bodies and regulatory planning.
By Dr. Hatem Rabeh · Published April 7, 2026
With notified body capacity constraints creating bottlenecks in 2026, QbD Group experts discuss strategies for medical device manufacturers to navigate the EU MDR transition, including early engagement with notified bodies and regulatory planning.
The comprehensive free database for medical device companies, FDA-cleared devices, EU Notified Bodies, competent authorities, clinical guidelines, and regulatory resources worldwide — 4,975 companies · 5,064 devices · 53 EU Notified Bodies · 1,129 resources & guidelines. Founded by Dr. Hatem Rabeh (MD, MSc Ing).